Download video

Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment

858 views

OncLive

5 years ago

Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment

Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment

Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment
1:12
Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment
by OncLive
Dr. Yorio on Treatment Options for Patients With Rare Mutations in Metastatic Lung Cancer
1:22
Dr. Yorio on Treatment Options for Patients With Rare Mutations in Metastatic Lung Cancer
by OncLive
Dr. Yorio on Searching for Biomarkers in Metastatic Lung Cancer
1:54
Dr. Yorio on Searching for Biomarkers in Metastatic Lung Cancer
by OncLive
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers
6:59
Ado-trastuzumab emtansine in patients with HER2 mutant lung cancers
by ecancer
Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC
1:10
Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC
by OncLive
Antibody drug conjugates in lung cancer
3:58
Antibody drug conjugates in lung cancer
by VJOncology
Strategies to Target HER2 in Lung Cancer
1:45
Strategies to Target HER2 in Lung Cancer
by American Lung Association
Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC
1:55
Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC
by Targeted Oncology
Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting
0:56
Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting
by OncLive
T-DM1 improves overall survival in previously treated advanced cancer patients
5:24
T-DM1 improves overall survival in previously treated advanced cancer patients
by ecancer
Adjuvant T-DM1 for Stage I HER2+ Breast Cancer
4:54
Adjuvant T-DM1 for Stage I HER2+ Breast Cancer
by PracticeUpdate
Dr. Tripathy on Trastuzumab Deruxtecan Versus T-DM1 in HER2-Expressing Breast Cancers
1:09
Dr. Tripathy on Trastuzumab Deruxtecan Versus T-DM1 in HER2-Expressing Breast Cancers
by OncLive
EMILIA Trial: T-DM1 in Metastatic Breast Cancer
4:52
EMILIA Trial: T-DM1 in Metastatic Breast Cancer
by OncLive
HER2- and MET-Mutation\/Amplification Therapies
4:07
HER2- and MET-Mutation\/Amplification Therapies
by OncLive
HER2+ Breast Cancer: Managing Patients on T-DM1
6:40
HER2+ Breast Cancer: Managing Patients on T-DM1
by Targeted Oncology
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
0:57
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
by OncLive
Lung Cancer Treatment Advances: What are Antibody Drug Conjugates?
1:45
Lung Cancer Treatment Advances: What are Antibody Drug Conjugates?
by Patient Empowerment Network
Lung Cancer Diagnosis: HER2 Mutation
3:26
Lung Cancer Diagnosis: HER2 Mutation
by The Cancer Guy
DESTINY-Lung01: cohort expansion results
2:37
DESTINY-Lung01: cohort expansion results
by VJOncology
Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1
1:38
Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1
by OncLive